NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Acquires Kadima Institute to Launch $100M Psychiatry Clinic Network
NRx Pharmaceuticals, Inc.
Nrx Pharmaceuticals Inc. (NRXP)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sage Rock Capital Management Atull Khanna | 0 | $0 | 0% | |
| 2. | Ionic Capital Management Bart Baum | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | ||
| 4. | 0 | $0 | 0% | ||
| 5. | Ursa Fund Management Andrew Hahn | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.17 | 40,000 | $46,800.00 | 84,634 | 2024-12-17 | Filing | |
| $0.32 | 35,000 | $11,196.50 | 105,000 | 2023-08-30 | Filing | |
| $0.29 | 70,000 | $20,125.00 | 570,000 | 2023-08-30 | Filing | |
| $0.33 | 100,000 | $33,000.00 | 446,332 | 2023-08-23 | Filing | |
| $0.32 | 200,000 | $64,400.00 | 346,332 | 2023-08-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.00 | 400,000 | $400,000.00 | 12,899,997 | 2022-12-07 | Filing | |
| $1.50 | 8,441 | $12,700.33 | 9,634,793 | 2022-11-30 | Filing | |
| $1.50 | 13,730 | $20,651.29 | 9,643,234 | 2022-11-29 | Filing | |
| $1.05 | 33,018 | $34,744.84 | 9,656,964 | 2022-11-17 | Filing | |
| $1.02 | 133,719 | $136,393.38 | 9,689,982 | 2022-11-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the NRx Pharmaceuticals First Quarter 2025 Earnings Call. At this time, all lines are in a listen-only mode.
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q4 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals 4Q and Full Year 2024 Earnings Call. At this time, all lines are in a listen only mode.
12 Best Psychedelic Stocks to Buy in 2025
In contrast to drugs like cocaine or marijuana, psychedelics are strong and give users access to a kind of "alternate reality." One class of hallucinogenic substances that can produce unusual states of...
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the NRx Pharmaceuticals Third Quarter 2024 Earnings Conference Call. At this time, all lines are in the listen-only mode.
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, everyone. And welcome to the NRx Pharmaceuticals Incorporated Second Quarter of 2024 Results Conference Call. Currently, all participants are in a listen-only mode.
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, everyone. And welcome to the NRx Pharmaceuticals, Inc. First Quarter of 2024 Results Conference Call [Operator Instructions].
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q4 2023 Earnings Call Transcript
Operator: Good morning everyone and welcome to the NRx Pharmaceuticals, Inc. Fourth Quarter and Full Year 2023 Results Conference Call.
11 Most Promising Psychedelic Stocks According to Hedge Funds
In this piece, we will take a look at the 11 most promising psychedelic stocks according to hedge funds.
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. This is the conference operator. Welcome to NRX Pharmaceuticals' Third Quarter 2023 Earnings Conference Call.
Billionaire Hedge Funds
